Trials / Completed
CompletedNCT01750970
Endoscopic Resection of Bladder Tumors
Endoscopic Resection of High Grade(TA, T1, Cis)Non-muscle Invasive Bladder Tumors: Modification of Usual Management of This Resection by Using the Blue Light and Evaluation of the Outcome: Should we Maintain the Dogma of Second Endoscopic Resection as a Principle?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Hopital Foch · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To confirm the benefit of endoscopic resection under fluorescence and blue light of high grade non-muscle invasive bladder tumor, and verifying if the second endoscopic resection recommended nowadays can be deleted.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Endoscopic resection under blue light (Hexvix®) | Endoscopic resection |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2012-12-01
- Completion
- 2013-12-01
- First posted
- 2012-12-17
- Last updated
- 2016-09-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01750970. Inclusion in this directory is not an endorsement.